NASDAQ · Healthcare · Medical - Devices
TriSalus Life Sciences, Inc.
TLSI
TriSalus Life Sciences, Inc. CEO Mary T. Szela · Market cap $89.6M.
$2.36
-2.20 · -48.18%
52w hi $7.9552w lo $2.22
Off 52w high 41.6%
78
STRONG
Current InsiderScore
Corp · 90d
5
5 buys · 0 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
5
3 strong · 2 notable
Analyst consensus
Strong Buy
Avg PT $10.50
Section 01
Recent Form 4 filings
5 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| Feb 23 | Gary B. Gordon | Buy | 9,756 | $4.10 | +$40K | 73 | |
| Feb 23 | Mary T Szela | CEO and President | Buy | 30,487 | $4.10 | +$125K | 74 |
| Feb 23 | William Valle | Buy | 30,487 | $4.10 | +$125K | 78 | |
| Feb 23 | Stansky Michael P | Buy | 117,198 | $4.10 | +$481K | 78 | |
| Feb 23 | Stansky Michael P | Buy | 243,900 | $4.10 | +$1000K | 78 |
Section 02
Recent STOCK Act disclosures
No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03
InsiderScore history
Rolling 12 months · peak score per month
JunJulAugSepOctNovDecJanFebMarAprMay